Depression

Although her grades didn’t suffer during the pandemic, Shekinah Glory Peter Mba, like many students, knew she wasn’t feeling well.  She endured episodes of depression. “It was bad, honestly,” said Peter Mba, a junior at East Orange High School. “This is probably the worst year ever. I realized all throughout my life, I was using school […]

When I was hospitalized for anxiety and depression in my early 20s, one of the patients at the facility — a young mom — started talking to me while she was waiting for her ECT, or electroconvulsive therapy, commonly known as shock therapy. How can a psychedelic party drug be a useful tool in a

Wellness This edition of the Mayo Clinic Q&A podcast features an #AskMayoMom episode hosted by Dr. Angela Mattke, a pediatrician at Mayo Clinic Children’s Center. Joining Mattke to discuss teens and depression are Dr. Paige Partain, a Mayo Clinic pediatrician, and Hannah Mulholland, a Mayo Clinic pediatric social worker. Written By: Mayo Clinic News Network | 1:21 pm, May 7, 2021

Perinatal mental illnesses affect between 7 and 20% of women globally, as well as men, yet they are still shrouded in stigma and prejudice. The Covid-19 pandemic has not improved the situation. Is it time for technology to step in? This content was published on May 21, 2021 – 06:00 May 21, 2021 – 06:00

Scientists say simple blood test can reveal depression  FOX 4 Dallas

ROCKFORD, Ill. (WIFR) – May is Mental Health Awareness Month and coping with mental illness can be challenging, especially during this pandemic. One area mental health director offers tips on how you can cope. SwedishAmerican’s Center for Mental Health is seeing depression and anxiety rates increase due to isolation and the unknown outlook of the

Evolving Management Strategies for Treatment-Resistant Depression – Episode 9 May 20, 2021 Steven P. Levine, MD , Angelos Halaris, MD, PhD, APA, ACNP, CINP Angelos Halaris, MD, PhD, APA, ACNP, CINP , Lisa Harding, MD , Patricia Ares-Romero, MD, FASAM Patricia Ares-Romero, MD, FASAM Best practices that can be applied when working with patients and

Mushroom Medicine: Cybin hopes its sublingual form of synthetic psilocybin will one day be an FDA-approved medicine to treat major depression disorder. getty Psychedelic drug development company Cybin will launch a phase two clinical trial on its sublingual formulation of psilocybin, the psychedelic compound found in “magic mushrooms”, for patients with Major Depressive Disorder later

Evolving Management Strategies for Treatment-Resistant Depression – Episode 10 May 20, 2021 Steven P. Levine, MD , Angelos Halaris, MD, PhD, APA, ACNP, CINP Angelos Halaris, MD, PhD, APA, ACNP, CINP , Lisa Harding, MD , Patricia Ares-Romero, MD, FASAM Patricia Ares-Romero, MD, FASAM Requirements that healthcare clinics must satisfy to become a certified treatment

Source/Disclosures Disclosures: Barkham reports being on the editorial board of the journal published by the British Association for Counselling and Psychotherapy (BACP), for which he is entitled to an honorarium, and previously being an unpaid member of the BACP Research Committee and Scientific Committee and receiving travel expenses, as well as having